Savaria Corp (SIS.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Savaria Corp (SIS.TO)

29.11

+0.49 (1.71%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

307 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 6 opinions in the last 12 months.

Savaria Corp (SIS-T) is experiencing a positive momentum due to its focus on the accessibility industry amidst a demographic trend of an aging population that prefers to age at home. Following challenges from tariffs that impacted its operations, the company has strategically shifted its production to the U.S. and is now compliant with CUSMA regulations, which helps in stabilizing its market position. Analysts note that a significant portion of its products is FDA-regulated, shielding them from tariff impacts. The company has shown resilience and growth potential, combined with cost-cutting measures and the introduction of new products. Its current yield of 2.69% and analysts' target price suggest prospects of further appreciation in stock value, making it an attractive long-term investment.

Consensus

Positive

Valuation

Fair Value

Similar

Amedisys, AMED

BUY

Stair lifts and mobility aids. Huge demographic tail winds. A very well managed company. A good distribution network in Canada. He really likes the company. Great growth ahead and a great segment to be in.

Wealthica Track your Stocks in your Watch List

COMMENT

He doesn’t cover this one formally, but did put it in one of his portfolios because he likes it. Thinks there is lots of opportunity here. Management knows what they are doing. The growth rate is there. Valuation is acceptable. He likes the demographic play they have on the healthcare market. Management owns a big chunk.

TOP PICK

Health care sector. Most of the rest in the sector is too expensive. They make accessibility equipment for the mobility challenged and do the conversion of minivans. It is a unique company. The family owns 50% of the stock.

SELL

Two businesses. One is for in-home lift systems. The second is elevators in your home for cars. The demographics for the medical lifts are obviously quite positive, but the others are negative. He sold because it was getting pricy.

TRADE

Made $0.16 a share last year and $0.13 last nine months. Agrees that demographics are important and this industry is growing. Cdn$ is negative for them. Have a strategy to buy distributors in North America.

BUY

A microcap. Trading at about 15 X EPS forward multiple. Nice growth through the years but are exposed to the US$. Reducing costs and making an acquisition. Margins should go up.

Showing 121 to 126 of 126 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Savaria Corp (SIS.TO)